@FiercePharma: Novartis scouts bolt-on deals of up to $3B. Article | Follow @FiercePharma
> Bristol-Myers Squibb and Roche said they would evaluate their respective cancer drugs in combination to treat a type of metastatic melanoma. Report
> Canadian regulators approved AstraZeneca's key new heart drug Brilinta, a boost for a product whose future in the all-important U.S. market is still uncertain. News
> Health experts said an unusually lethal strain of E. coli, which has infected more than 1,500 in Germany, was a previously unknown drug-resistant variant of the bacteria. Article
> A sharp rise in a type of throat cancer among men is increasingly being linked to HPV, the sexually transmitted human papillomavirus that can cause cervical cancer in women. Report
> Scientists say they are one step closer to establishing a way to double the U.S. supply of flu vaccine, thus warding off the possibility of shortages. Report
Biotech News
@FierceBiotech: J&J dumps $625M diabetes drug pact with Diamyd. Item | Follow @FierceBiotech
@JohnCFierce: Silenor has to be one of the lamest new products I've seen in recent times. | Follow @JohnCFierce
> Clovis teams with Roche on companion diagnostic for covalent cancer drug. Item
> Merck CEO Frazier stands by his $8B R&D gamble. News
> Ziopharm vows to wow cancer field with synthetic biology drugs. Story
> UK pharma czar sees new "innovation ecosystem" R&D model emerge. Article
> GSK, Theravance report Ph3 successes for COPD treatment. Report
> BMS, Roche join forces and drugs on combo melanoma program. Item
Vaccines News
> Lymphoma vaccine extends survival in late-stage study. News
> MediGene, Johns Hopkins join on HPV vax research. Report
> GAVI board hit with conflict of interest woes. Item
> Intercell recalls encephalitis vaccine batch. Story
Manufacturing News
> Congress queries ICE over 2008 heparin contamination. Report
> Unicef price postings aim for lower-cost vaccines. Story
> DHL bolsters cold chain with Sentry sensor device. Item
> FDA-TRACK update shows jump in FOIA requests. Story
> Sanofi dictates contractor choice, re-org to Genzyme. Article
> FDA: 5 recalls traced to excipients in 2010. News
And Finally... Why aren't there more Wall Street whistleblowers? Ask David Maris, the former Bank of America analyst who first questioned a 2003 Biovail quarterly report later investigated by the Securities & Exchange Commission. Report